Barclays Joins the Upgrade Trail as CSTM Drifts vs Peers

Constellium SE makes aluminum products for aerospace, automotive and packaging markets. The stock closed at $23.11 on October 30, down 3.8% on the day and roughly flat on the week, while its closest peers gained a median 3.4% over the same period.

The gap between where analysts think this stock belongs and where it is trading has widened sharply since Q3 earnings. The consensus price target is $30.04. The stock is 23% below that.

Analyst Desk Shifts After Earnings

Barclays was the latest to move. Richard Garchitorena raised his target to $30 from $28 on October 30 while keeping an Equal-Weight rating. That follows JP Morgan's more aggressive action a day earlier: Bill Peterson upgraded to Overweight from Neutral and lifted his target to $35 from $34, implying 43% upside from the current price. Both moves run in the opposite direction from what the rest of the desk had been doing. Wells Fargo's Timna Tanners cut her target to $33 from $38 on October 29, maintaining Overweight. UBS trimmed to $32 from $34 in early October. Deutsche Bank cut to $36 from $39 on the same day. Barclays itself had set a $28 target only two weeks earlier when it initiated coverage.

The net result is a desk that is constructive on rating (two Overweights, one Buy, two Equal-Weights in the recent mix) but operating with targets that have been stepped down from the levels in place before the Q3 print. JP Morgan's $35 is now the high-water mark among recent movers.

Options Positioning Stays Cautious

The options market has not shared the analysts' constructive tilt. The put/call ratio sat at 0.456 on October 30, about two standard deviations above its 20-day mean of 0.42. That is a slight moderation from the 2.9 standard deviation reading on October 28, but put demand has stayed elevated since the earnings date. Against the 52-week range of 0.14 to 1.39, the current level is unremarkable in absolute terms. The direction of the move since earnings is what stands out.

Borrow Market Signals No New Short Conviction

One data point cuts against the cautious options read. Borrow availability remains extremely loose. Over 133 million shares are available to lend, against roughly 6.4 million currently borrowed. The cost to borrow is 0.50%, low by any measure, and down from around 0.67% in mid-October. Short interest is 4.6% of the free float, up 9% on the day as of October 30 but still 10% below where it was a month ago. The borrow market shows no sign of fresh short positioning building.

American Century added 2.1 million shares in the quarter to September 30, the largest institutional build in the top-15 holder list over the period. Caisse des Depots (CDC) holds a 13D activist stake at 6.2%, as last disclosed May 28, though Schedule 13D positions are event-driven and the current level may differ.

• Stock: $23.11, down 3.8% on October 30, down 6% over one month
• Consensus target: $30.04 (JP Morgan at $35 is the post-earnings high)
• PCR: 0.456, approximately two standard deviations above the 20-day mean
• Short interest: 4.6% of free float; 133 million shares available to borrow
• Cost to borrow: 0.50%, low level, down from the month's peak
• Next earnings: February 17, 2027